Boston Therapeutics, Inc. Introductory Social Media Launch (www.bostonti.com)
January 16, 2018 10:05 ET
|
Boston Therapeutics, Inc.
LAWRENCE, Mass., Jan. 16, 2018 (GLOBE NEWSWIRE) -- Boston Therapeutics, Inc. (OTCQB:BTHE) begun the roll-out of its new Multimedia Internet Platform. The redesigned website offers global insight...
Boston Therapeutics, Inc. Expands Partnership with APC to Distribute in Korea
December 14, 2017 12:53 ET
|
Boston Therapeutics, Inc.
LAWRENCE, Mass., Dec. 14, 2017 (GLOBE NEWSWIRE) -- Following the extension of the licensing and distribution agreement with Asian based partner, Advance Pharmaceutical Company Limited (APC), a...
Boston Therapeutics, Inc. Announces New Dosing Regimen for BTI320
December 06, 2017 12:12 ET
|
Boston Therapeutics, Inc.
LAWRENCE, Mass., Dec. 06, 2017 (GLOBE NEWSWIRE) -- Boston Therapeutics, Inc is pleased to announce that effective sugar reduction with the investigative BTI320 formulation requires only one tablet....
Boston Therapeutics Shareholder Update
November 17, 2017 09:10 ET
|
Boston Therapeutics, Inc.
LAWRENCE, Mass., Nov. 17, 2017 (GLOBE NEWSWIRE) -- On November 16, 2017, Carl W. Rausch, CEO of Boston Therapeutics, Inc., headquartered in Lawrence MA, (OTCQB:BTHE) (“BTI” or the “Company”),...
BOSTON THERAPEUTICS Reports Data from the POC Asia Trial at the American Diabetes Association’s 77th Scientific Sessions
June 19, 2017 08:30 ET
|
Boston Therapeutics, Inc.
LAWRENCE, Mass., June 19, 2017 (GLOBE NEWSWIRE) -- Mr. Carl Rausch, CEO of Boston Therapeutics, Inc. (OTCQB:BTHE) and its Asian partner Advance Pharmaceutical Company Limited, Hong Kong had data...
Boston Therapeutics secures $1 Million financing for the first phase Multi-Centre International Ph II-III Trial
April 26, 2017 11:14 ET
|
Boston Therapeutics
LAWRENCE, MA--(Marketwired - Apr 26, 2017) - Boston Therapeutics, Inc. (OTCQB: BTHE) and its Asian partner Advance Pharmaceutical Company Limited, Hong Kong, announced today the fully financed new...
Boston Therapeutics Business Update
February 07, 2017 07:51 ET
|
Boston Therapeutics
LAWRENCE, MA--(Marketwired - Feb 7, 2017) - On February 1, 2017 Boston Therapeutics, Inc., headquartered in Lawrence MA, (OTCQB: BTHE) disclosed its restructured operations activity in a two...
Boston Therapeutics Announces Innovation Grant
October 13, 2016 10:16 ET
|
Boston Therapeutics
LAWRENCE, MA--(Marketwired - Oct 13, 2016) - Boston Therapeutics, Inc. (OTCQB: BTHE) - Today Boston Therapeutics and Advance Pharmaceutical Co., Ltd., which holds a license for the...
Boston Therapeutics Reports Positive Topline Data From Proof of Concept Asia Trial
October 06, 2016 08:22 ET
|
Boston Therapeutics
LAWRENCE, MA--(Marketwired - Oct 6, 2016) - Boston Therapeutics, Inc. (OTCQB: BTHE) and its Asian partner Advance Pharmaceutical Company Limited, Hong Kong presented today the positive topline data...
Boston Therapeutics Completes Private Offering, Appoints New CEO
October 03, 2016 13:15 ET
|
Boston Therapeutics
LAWRENCE, MA--(Marketwired - Oct 3, 2016) - Boston Therapeutics, Inc. (OTCQB: BTHE) ("Boston Therapeutics" or the "Company") announced that it closed a private placement yielding gross proceeds to...